Figure 2From: Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot studyIndividual 0–9 hours area under the curve (AUC) for 6 renal transplant patients at week 13 compared to week 1. Solid lines denote belatacept patients (n = 3) while broken lines represent CsA patients (n = 3). Data are provided for A: mycophenolic acid (MPA) AUC0–9 h, B: inosine monophosphate dehydrogenase (IMPDH) activity AUC0–9 h and C: IMPDH1 expression AUC0–9 h.Back to article page